Effects of anti‐IL5 biological treatments on blood IgE levels in severe asthmatic patients: A real‐life multicentre study (BIONIGE)

BACKGROUND: Mepolizumab and benralizumab are clinically effective biological treatments for severe eosinophilic asthmatic patients by hampering eosinophilic inflammation. The effects of these compound on the immunoglobulin (Ig)E T2 component are virtually unknown. OBJECTIVES: To evaluate the change...

Descripción completa

Detalles Bibliográficos
Autores principales: Contoli, Marco, Santus, Pierachille, Menzella, Francesco, Rocchi, Cindy, Radovanovic, Dejan, Baraldi, Federico, Martelli, Chiara, Casanova, Serena, Barbetta, Carlo, Micheletto, Claudio, Scichilone, Nicola, Beghè, Bianca, Carpagnano, Elisiana, Papi, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988861/
https://www.ncbi.nlm.nih.gov/pubmed/35423001
http://dx.doi.org/10.1002/clt2.12143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988861/
https://www.ncbi.nlm.nih.gov/pubmed/35423001
http://dx.doi.org/10.1002/clt2.12143

Ejemplares similares